New clinical application prospects of artemisinin and its derivatives: a scoping review

Yangmu Huang, Yang Yang, Guangqi Liu, Ming Xu · 2023

Read New clinical application prospects of artemisinin and its derivatives: a scoping review by Yangmu Huang, Yang Yang, Guangqi Liu, Ming Xu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10712159.txt.

Description

Yangmu Huang and co-authors published this scoping review in 2023 on artemisinin, the famed malaria drug drawn from a Chinese herb. Work hints the drug and its kin may also fight parasites, viruses, tumors, swelling, and skin ills. The team swept many data banks for clinical studies beyond malaria, in English and Chinese, up to late 2021. Seventy-seven studies made the cut.

Parasite studies led the count, with tumor, swelling, virus, and skin work behind. Most studies ran in Asia, then Africa. Virus work lagged, stuck mostly in early safety trials. Side effects were mild in nearly all reports, with one study noting a harsh event. Gains showed for most uses, though combo therapy for non-malaria parasites stayed in dispute. The authors map where proof is strong and where trials should go next.

Catalog record

CREATORYangmu Huang, Yang Yang, Guangqi Liu, Ming Xu
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10712159

Browse the full library · About the Tower of Babel